z-logo
open-access-imgOpen Access
Age-associated repression of type 1 inositol 1, 4, 5-triphosphate receptor impairs muscle regeneration
Author(s) -
Jeong Yi Choi,
Chae Young Hwang,
Bora Lee,
Seung-Min Lee,
Young Jae Bahn,
KwangPyo Lee,
Moonkyung Kang,
Yeon Soo Kim,
SunHee Woo,
JaeYoung Lim,
Eunhee Kim,
Ki-Sun Kwon
Publication year - 2016
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.101039
Subject(s) - skeletal muscle , c2c12 , myocyte , sarcopenia , biology , mapk/erk pathway , endocrinology , medicine , muscle atrophy , microbiology and biotechnology , kinase , myogenesis , insulin like growth factor 1 receptor , receptor , biochemistry , growth factor
Skeletal muscle mass and power decrease with age, leading to impairment of mobility and metabolism in the elderly. Ca 2+ signaling is crucial for myoblast differentiation as well as muscle contraction through activation of transcription factors and Ca 2+ -dependent kinases and phosphatases. Ca 2+ channels, such as dihydropyridine receptor (DHPR), two-pore channel (TPC) and inositol 1,4,5-triphosphate receptor (ITPR), function to maintain Ca 2+ homeostasis in myoblasts. Here, we observed a significant decrease in expression of type 1 IP3 receptor (ITPR1), but not types 2 and 3, in aged mice skeletal muscle and isolated myoblasts, compared with those of young mice. ITPR1 knockdown using shRNA-expressing viruses in C2C12 myoblasts and tibialis anterior muscle of mice inhibited myotube formation and muscle regeneration after injury, respectively, a typical phenotype of aged muscle. This aging phenotype was associated with repression of muscle-specific genes and activation of the epidermal growth factor receptor (EGFR)-Ras-extracellular signal-regulated kinase (ERK) pathway. ERK inhibition by U0126 not only induced recovery of myotube formation in old myoblasts but also facilitated muscle regeneration after injury in aged muscle. The conserved decline in ITPR1 expression in aged human skeletal muscle suggests utility as a potential therapeutic target for sarcopenia, which can be treated using ERK inhibition strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom